Sai Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 ,inter alia, to consider and approve 1. Un-audited financial results ....
SAIPARENT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sai Parenterals Ltd has informed the exchanges about a board meeting scheduled for 23 May 2026. The meeting will consider unaudited financial results (standalone and consolidated) for the quarter and nine months ended December 31, 2025, along with limited review reports. Additionally, the board will consider audited financial results for the quarter and year ended March 31, 2026, which would be the Q4 and full year FY2025-26 results. This appears to be a routine quarterly results meeting with no extraordinary agenda items mentioned. The company has provided advance notice as required under SEBI LODR Regulations.
This is a standard board meeting intimation for quarterly and annual financial results. Investors should expect Q3 and FY2025-26 annual results to be announced after the meeting. No immediate stock impact expected from this routine filing.